Your browser doesn't support javascript.
loading
Prevalence of cardiac abnormalities and heart failure in unselected out-patients with type 2 diabetes mellitus and associated clinical factors: Real-world evidence from an Indian registry.
Rajput, Rajesh; Mohan, J C; Sawhney, J P S; Dalal, Jamshed; Mullasari, Ajit; Vasnawala, Hardik; Kumar, Amit; Hs, Bharath; Sarda, Shital.
Afiliación
  • Rajput R; PGIMS, Rohtak, India.
  • Mohan JC; Institute of Heart & Vascular Diseases, Jaipur Golden Hospital, Sector 3, Rohini, New Delhi, India. Electronic address: a51hauzkhas@gmail.com.
  • Sawhney JPS; Sir Ganga Ram Hospital, Delhi, India.
  • Dalal J; Kokilaben Dhirubhai Ambani Hospital, Mumbai, India.
  • Mullasari A; MMM Hospital, Chennai, India.
  • Vasnawala H; Medical Affairs, AstraZeneca Pharma India Ltd, India.
  • Kumar A; Medical Affairs, AstraZeneca Pharma India Ltd, India.
  • Hs B; Medical Affairs, AstraZeneca Pharma India Ltd, India.
  • Sarda S; Medical Affairs, AstraZeneca Pharma India Ltd, India.
Indian Heart J ; 75(6): 436-442, 2023.
Article en En | MEDLINE | ID: mdl-37884126
OBJECTIVE: Type 2 diabetes mellitus (T2DM) is known to be associated with development of left ventricular (LV) dysfunction and heart failure (HF). The study aimed to determine the prevalence of LV dysfunction and HF in unselected out-patients with T2DM with no previous cardiac history and to correlate LV dysfunction and HF with demographic and comorbid characteristics. METHODS: This cross-sectional study conducted at 27 centers in India captured demographic and clinical data through electronic case record forms. B-type natriuretic peptide of >105 pg/mL was used to diagnose HF and two-dimensional echocardiography was used to assess LV dysfunction. RESULTS: Of the 615 patients, 54.3 % (n = 334) were males; mean age was 57.4 ± 10.48 years. More than one-third of the patients had T2DM duration of >10 years (n = 238; 38.7 %), with hypertension as the most prevalent comorbidity (n = 372, 78.6 %). Approximately 61.3 % of the patients had LV hypertrophy. The mean LV mass was 135.0 ± 56.16 g (95 % CI 130.28, 139.70). The prevalence of any type of LV dysfunction, including systolic or diastolic dysfunction and HF was 55 % (95 % CI 51.0, 59.0) and 10 % (95 % CI 7.0, 12.0), respectively. A negligible but statistically significant correlation was observed between LV dysfunction and T2DM duration (p = 0.011), alongside HF and age (p < 0.0001). CONCLUSION: Real-world data from this registry from India demonstrates a substantial burden of LV dysfunction and HF in individuals with T2DM in India. It is imperative to formulate strategies for early identification of LV dysfunction in individuals with T2DM for prevention and consequent management of HF.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Disfunción Ventricular Izquierda / Diabetes Mellitus Tipo 2 / Insuficiencia Cardíaca Idioma: En Revista: Indian Heart J Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Disfunción Ventricular Izquierda / Diabetes Mellitus Tipo 2 / Insuficiencia Cardíaca Idioma: En Revista: Indian Heart J Año: 2023 Tipo del documento: Article